Skip to main content
Erschienen in: Drug Safety 7/2010

01.07.2010 | Current Opinion

Recurrence of Adverse Drug Reactions following Inappropriate Re-Prescription

Better Documentation, Availability of Information and Monitoring are Needed

verfasst von: Dr Carolien M. J. van der Linden, Paul A. F. Jansen, Rob J. van Marum, René J. E. Grouls, Erik H. M. Korsten, Antoine C. G. Egberts

Erschienen in: Drug Safety | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Adverse drug reactions (ADRs) are a common, and often preventable, cause of hospital admission, especially in the elderly, and can occur during hospitalization.
In this current opinion article, we present three cases of recurrence of a serious ADR due to re-prescription of a withdrawn medication that highlight the need for a system to prevent the undesirable re-prescription of medications withdrawn because of an ADR. In addition, we describe an electronic system that could help prevent undesirable re-prescription following an ADR. Such a system should document ADRs systematically at the patient level, make this information available to relevant healthcare providers and the patient, and flag re-prescription of the offending drug. The effectiveness and cost effectiveness of such a system would need to be determined.
Literatur
1.
Zurück zum Zitat Edwards R, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef Edwards R, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef
2.
Zurück zum Zitat Leendertse AJ, Egberts ACG, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890–6PubMedCrossRef Leendertse AJ, Egberts ACG, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890–6PubMedCrossRef
3.
Zurück zum Zitat Mannesse CK, Derkx FH, de Ridder MA, et al. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–8PubMedCrossRef Mannesse CK, Derkx FH, de Ridder MA, et al. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–8PubMedCrossRef
4.
Zurück zum Zitat van der Linden CMJ, Kerskes CH, Bijl AMH, et al. Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med 2006; 166: 1666–7PubMedCrossRef van der Linden CMJ, Kerskes CH, Bijl AMH, et al. Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med 2006; 166: 1666–7PubMedCrossRef
5.
Zurück zum Zitat Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222–5PubMedCrossRef Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222–5PubMedCrossRef
6.
Zurück zum Zitat Naranjo CAA. Method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45PubMedCrossRef Naranjo CAA. Method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45PubMedCrossRef
7.
Zurück zum Zitat Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description and instructions for use. JAMA 1979; 242: 623–32PubMedCrossRef Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description and instructions for use. JAMA 1979; 242: 623–32PubMedCrossRef
Metadaten
Titel
Recurrence of Adverse Drug Reactions following Inappropriate Re-Prescription
Better Documentation, Availability of Information and Monitoring are Needed
verfasst von
Dr Carolien M. J. van der Linden
Paul A. F. Jansen
Rob J. van Marum
René J. E. Grouls
Erik H. M. Korsten
Antoine C. G. Egberts
Publikationsdatum
01.07.2010
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 7/2010
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/11532350-000000000-00000

Weitere Artikel der Ausgabe 7/2010

Drug Safety 7/2010 Zur Ausgabe